The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
A Role for Tubular Necroptosis in Cisplatin-Induced AKI
Open accessAbstract
Cell death and inflammation in the proximal tubules are the hallmarks of cisplatin-induced AKI, but the mechanisms underlying these effects have not been fully elucidated. Here, we investigated whether necroptosis, a type of programmed necrosis, has a role in cisplatin-induced AKI. We found that inhibition of any of the core components of the necroptotic pathway-receptor-interacting protein 1 (RIP1), RIP3, or mixed lineage kinase domain-like protein (MLKL)-by gene knockout or a chemical inhibitor diminished cisplatin-induced proximal tubule damage in mice. Similar results were obtained in cultured proximal tubular cells. Furthermore, necroptosis of cultured cells could be induced by cisplatin or by a combination of cytokines (TNF-α, TNF-related weak inducer of apoptosis, and IFN-γ) that were upregulated in proximal tubules of cisplatin-treated mice. However, cisplatin induced an increase in RIP1 and RIP3 expression in cultured tubular cells in the absence of cytokine release. Correspondingly, overexpression of RIP1 or RIP3 enhanced cisplatin-induced necroptosis in vitro. Notably, inflammatory cytokine upregulation in cisplatin-treated mice was partially diminished in RIP3- or MLKL-deficient mice, suggesting a positive feedback loop involving these genes and inflammatory cytokines that promotes necroptosis progression. Thus, our data demonstrate that necroptosis is a major mechanism of proximal tubular cell death in cisplatin-induced nephrotoxic AKI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase
Sun, L., Wang, H., Wang, Z., He, S., Chen, S., Liao, D., Wang, L., Yan, J., Liu, W., Lei, X., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.031 · Cited by 2,698
Cho, Y., Challa, S., Moquin, D., Genga, R., Ray, T. D., Guildford, M., & Chan, F. K.-M. (2009) · Cell · doi:10.1016/j.cell.2009.05.037 · Cited by 2,435
RIP3, an Energy Metabolism Regulator That Switches TNF-Induced Cell Death from Apoptosis to Necrosis
Zhang, D.-W., Shao, J., Lin, J., Zhang, N., Lu, B.-J., Lin, S.-C., Dong, M.-Q., & Han, J. (2009) · Science · doi:10.1126/science.1172308 · Cited by 1,931
Self-citationWang, H., Sun, L., Su, L., Rizo, J., Liu, L., Wang, L.-F., Wang, F.-S., & Wang, X. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.03.003 · Cited by 1,563
Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis
Cai, Z., Jitkaew, S., Zhao, J., Chiang, H.-C., Choksi, S., Liu, J., Ward, Y., Wu, L.-G., & Liu, Z.-G. (2014) · Nature Cell Biology · doi:10.1038/ncb2883 · Cited by 1,322
The Inflammatory Response to Cell Death
Rock, K. L., & Kono, H. (2008) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.3.121806.151456 · Cited by 912
Arany, I., & Safirstein, R. L. (2003) · Seminars in Nephrology · doi:10.1016/s0270-9295(03)00089-5 · Cited by 906
Two independent pathways of regulated necrosis mediate ischemia–reperfusion injury
Linkermann, A., Bräsen, J. H., Darding, M., Jin, M. K., Sanz, A. B., Heller, J.-O., De Zen, F., Weinlich, R., Ortiz, A., Walczak, H., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1305538110 · Cited by 554
Newton, K., Sun, X., & Dixit, V. M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.4.1464-1469.2004 · Cited by 551
Mlkl knockout mice demonstrate the indispensable role of Mlkl in necroptosis
Wu, J., Huang, Z., Ren, J., Zhang, Z., He, P., Li, Y., Ma, J., Chen, W., Zhang, Y., Zhou, X., et al. (2013) · Cell Research · doi:10.1038/cr.2013.91 · Cited by 462
Self-citationLieberthal, W., Triaca, V., & Levine, J. (1996) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1996.270.4.f700 · Cited by 449
Programmed necrosis: backup to and competitor with apoptosis in the immune system
Han, J., Zhong, C.-Q., & Zhang, D.-W. (2011) · Nature Immunology · doi:10.1038/ni.2159 · Cited by 367
Self-citationCisplatin-Induced Renal Cell Apoptosis: Caspase 3-Dependent and -Independent Pathways
Cummings, B. S., & Schnellmann, R. G. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.302.1.8 · Cited by 358
Distinct roles of RIP1–RIP3 hetero- and RIP3–RIP3 homo-interaction in mediating necroptosis
Wu, X.-N., Yang, Z.-H., Wang, X.-K., Zhang, Y., Wan, H., Song, Y., Chen, X., Shao, J., & Han, J. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2014.77 · Cited by 299
Self-citationTNFR2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure
Ramesh, G., & Reeves, W. B. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00101.2003 · Cited by 282
A Role of RIP3-Mediated Macrophage Necrosis in Atherosclerosis Development
Lin, J., Li, H., Yang, M., Ren, J., Huang, Z., Han, F., Huang, J., Ma, J., Zhang, D., Zhang, Z., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2012.12.012 · Cited by 268
Self-citationChen, W., Zhou, Z., Li, L., Zhong, C.-Q., Zheng, X., Wu, X., Zhang, Y., Ma, H., Huang, D., Li, W., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.435545 · Cited by 266
Self-citationRamachandran, A., McGill, M. R., Xie, Y., Ni, H.-M., Ding, W.-X., & Jaeschke, H. (2013) · Hepatology · doi:10.1002/hep.26547 · Cited by 257
The pathological role of Bax in cisplatin nephrotoxicity
Wei, Q., Dong, G., Franklin, J., & Dong, Z. (2007) · Kidney International · doi:10.1038/sj.ki.5002256 · Cited by 228
Faubel, S., Ljubanovic, D., Reznikov, L., Somerset, H., Dinarello, C. A., & Edelstein, C. L. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.66010.x · Cited by 196
Cytokine cooperation in renal tubular cell injury: The role of TWEAK
Justo, P., Sanz, A. B., Sanchez-Niño, M. D., Winkles, J. A., Lorz, C., Egido, J., & Ortiz, A. (2006) · Kidney International · doi:10.1038/sj.ki.5001866 · Cited by 165
Programmed necrosis in acute kidney injury
Linkermann, A., Zen, F. D., Weinberg, J. M., Kunzendorf, U., & Krautwald, S. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs373 · Cited by 123
Cancer therapy and renal injury
Schrier, R. W. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16568 · Cited by 116
Ligation independent cloning irrespective of restriction site compatibility
Li, C. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.20.4165 · Cited by 103
Cancer therapy and renal injury
Schrier, R. W. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216568 · Cited by 93
Poly(ADP-ribose) polymerase 1 activation is required for cisplatin nephrotoxicity
Kim, J., Long, K. E., Tang, K. L., & Padanilam, B. J. (2012) · Kidney International · doi:10.1038/ki.2012.64 · Cited by 88
Endotoxin and cisplatin synergistically stimulate TNF-α production by renal epithelial cells
Ramesh, G., Kimball, S. R., Jefferson, L. S., & Reeves, W. B. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00277.2006 · Cited by 64
Yang, X., Lin, Z., Zhao, N., Zhou, L., Liu, F., Cichacz, Z. A., Zhang, L., Zhan, Q., & Zhao, X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100127 · Cited by 54
Self-citationSridevi, P., Nhiayi, M. K., & Wang, J. Y. J. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.42 · Cited by 35
Amelioration of cisplatin-induced nephrotoxicity in peroxiredoxin I-deficient mice
Okada, K., Dong-mei, M., Warabi, E., Morito, N., Akiyama, K., Murata, Y., Yamagata, K., Bukawa, H., Shoda, J., Ishii, T., et al. (2012) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-012-2046-0 · Cited by 9
Cited by
Necroptosis: Mechanisms and Relevance to Disease
Galluzzi, L., Kepp, O., Chan, F. K.-M., & Kroemer, G. (2017) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-052016-100247 · Cited by 713
Ferroptosis, but Not Necroptosis, Is Important in Nephrotoxic Folic Acid–Induced AKI
Martin-Sanchez, D., Ruiz-Andres, O., Poveda, J., Carrasco, S., Cannata-Ortiz, P., Sanchez-Niño, M. D., Ruiz Ortega, M., Egido, J., Linkermann, A., Ortiz, A., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015121376 · Cited by 564
Cisplatin nephrotoxicity: new insights and therapeutic implications
Tang, C., Livingston, M. J., Safirstein, R., & Dong, Z. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00631-7 · Cited by 548
ACSL4 deficiency confers protection against ferroptosis-mediated acute kidney injury
Wang, Y., Zhang, M., Bi, R., Su, Y., Quan, F., Lin, Y., Yue, C., Cui, X., Zhao, Q., Liu, S., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102262 · Cited by 431
Self-citationRegulated cell death pathways in kidney disease
Sanz, A. B., Sanchez-Niño, M. D., Ramos, A. M., & Ortiz, A. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-023-00694-0 · Cited by 393
Metadata
- Authors
- Xu, Y., Ma, H., Shao, J., Wu, J., Zhou, L., Zhang, Z., Wang, Y., Huang, Z., Ren, J., Liu, S., Chen, X., & Han, J.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2015-11
- Volume
- 26
- Issue
- 11
- Pages
- 2647-2658
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2076990941
- Cited by
- 354
- References
- 30
- FWCI
- 16.75
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.